Le traitement endoscopique du reflux gastro-œsophagien : gadget médiatique ou réelle promesse ? = Endoscopic treatment of gastroesophageal reflux diseaseGALMICHE, Jean-Paul; BAROUK, Jérome.Hépato-gastro (Montrouge). 2001, Vol 8, Num 5, pp 325-329, issn 1253-7020Article

Pharmacological targets in gastro-oesophageal reflux diseasePICHE, Thierry; GALMICHE, Jean Paul.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 97, Num 6, pp 333-341, issn 1742-7835, 9 p.Article

Facteurs prédictifs de réponse à la chirurgie anti-refluxTHIBAULT, Ronan; GALMICHE, Jean-Paul.Hépato-gastro (Montrouge). 2006, Vol 13, Num 6, pp 459-464, issn 1253-7020, 6 p.Article

Millennium GORD: Diagnosis and Treatment with New Generation PPIs. European GI Consensus: Roads to Acid Suppression (Sessions I and II), September 28-30, 2000, Rhodes, GreeceBLUM, André; GALMICHE, Jean-Paul.European journal of gastroenterology & hepatology. 2001, Vol 13, issn 0954-691X, 49 p., SUP1Conference Proceedings

Reflux disease : the disorder of the third millenniumHOLTMANN, Gerald.European journal of gastroenterology & hepatology. 2001, Vol 13, pp S5-S11, issn 0954-691X, SUP1Conference Paper

On-demand therapy for gastro-oesophageal reflux diseaseBYTZER, Peter.European journal of gastroenterology & hepatology. 2001, Vol 13, pp S19-S22, issn 0954-691X, SUP1Conference Paper

Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?LUNDELL, Lars.European journal of gastroenterology & hepatology. 2001, Vol 13, pp S23-S27, issn 0954-691X, SUP1Conference Paper

New-generation proton pump inhibitors : overcoming the limitations of early-generation agentsROBINSON, Malcolm.European journal of gastroenterology & hepatology. 2001, Vol 13, pp S43-S47, issn 0954-691X, SUP1Conference Paper

Esophageal mucosal defence : recent advances. SymposiumSCARPIGNATO, Carmelo; GALMICHE, Jean Paul; GIULI, Robert et al.Digestion. 1995, Vol 56, issn 0012-2823, 63 p., SUP1Conference Proceedings

Improving on PPI-based therapy of GORDSACHS, George.European journal of gastroenterology & hepatology. 2001, Vol 13, pp S35-S41, issn 0954-691X, SUP1Conference Paper

Endoluminal therapies for gastro-oesophageal reflux diseaseGALMICHE, Jean Paul; BRULEY DES VARANNES, Stanislas.Lancet (British edition). 2003, Vol 361, Num 9363, pp 1119-1121, issn 0140-6736, 3 p.Article

LEPTINE ET TISSU ADIPEUX MÉSENTÉRIQUE DANS L'INFLAMMATION INTESTINALE = LEPTIN AND MESENTERIC ADIPOSE TISSUE IN INTESTINAL INFLAMMATIONBarbier, Maryse; Galmiche, Jean-Paul.2000, 263 p.Thesis

Oesophageal defence mechanismsHOPWOOD, D.Digestion. 1995, Vol 56, pp 5-8, issn 0012-2823, SUP1Conference Paper

Systemic factors in esophageal mucosal protectionTOBEY, N. A.Digestion. 1995, Vol 56, pp 38-44, issn 0012-2823, SUP1Conference Paper

Non-erosive reflux disease : part of the spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both?QUIGLEY, Eamonn M. M.European journal of gastroenterology & hepatology. 2001, Vol 13, pp S13-S18, issn 0954-691X, SUP1Conference Paper

Shortcomings of the first-generation proton pump inhibitorsTYTGAT, Guido N. J.European journal of gastroenterology & hepatology. 2001, Vol 13, pp S29-S33, issn 0954-691X, SUP1Conference Paper

Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations : Treatment resultsGALMICHE, Jean Paul.Drugs (Basel). 2006, Vol 66, pp 7-13, issn 0012-6667, 7 p., SUP1Conference Paper

Adaptation to low-protein diet increases inhibition of gastric emptying by CCKLERAY, Véronique; SEGAIN, Jean-Pierre; CHERBUT, Christine et al.Peptides (New York, NY. 1980). 2003, Vol 24, Num 12, pp 1929-1934, issn 0196-9781, 6 p.Article

Vasoactive intestinal peptide is involved in the inhibitory effect of interleukin-1β on the jejunal contractile response induced by acetylcholine : Tube digestif et pancréas = Digestive tract and pancreasAUBE, Anne-Catherine; CHERBUT, Christine; ROZE, Claude et al.Gastroentérologie clinique et biologique. 2001, Vol 25, Num 12, pp 1090-1095, issn 0399-8320Article

How does the esophageal epithelium maintain its integrity ?TOBEY, N. A.Digestion. 1995, Vol 56, pp 45-50, issn 0012-2823, SUP1Conference Paper

Do salivary organic components play a protective role in health and disease of the esophageal mucosa ?SAROSIEK, J; MCCALLUM, R. W.Digestion. 1995, Vol 56, pp 32-37, issn 0012-2823, SUP1Conference Paper

Evaluation du diagnostic endoscopique de l'endobrachyoesophage : Audit de 346 comptes rendus = Evaluation of endoscopic diagnosis of Barrett's esophagus based on analysis of 346 reportsGORLOT, Ingrid; BRULEY DES VARANNES, Stanislas; LE RHUN, Marc et al.Gastroentérologie clinique et biologique. 2003, Vol 27, Num 8-9, pp 700-707, issn 0399-8320, 8 p.Article

Définition et méthodes de diagnostic de l'œsophage de Barrett : Œsophage de Barrett = Definition and diagnostic methods for Barrett's esophagusCORON, Emmanuel; MATYSIAK-BUDNIK, Tamara; LE CHEVALIER DE PREVILLE, Mathieu et al.Cancéro digest. 2009, Vol 1, Num 4, pp 265-271, issn 1953-5171, 7 p.Article

Glutamine metabolism in Crohn's disease: a stable isotope studyBOURREILLE, Arnaud; HUMBERT, Bernard; MAUGERE, Pascale et al.Clinical nutrition (Edinburgh). 2004, Vol 23, Num 5, pp 1167-1175, issn 0261-5614, 9 p.Article

Structure and role of Langerhans' cells in the human oesophageal epitheliumTERRIS, B; POTET, F.Digestion. 1995, Vol 56, pp 9-14, issn 0012-2823, SUP1Conference Paper